Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government
The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week.
The Argentine government has pledged to remove obstacles that could hinder the entry of the Indian pharmaceutical industry, according to the Commerce Ministry. This move aims to open up new opportunities for Indian pharmaceutical companies and enhance access to affordable and quality healthcare in Argentina. During his recent visit to Buenos Aires, Commerce Secretary Rajesh Agarwal discussed the issue with Argentine officials as part of the India-Argentina Joint Trade Committee meeting.
The talks took place at Palacio San Martín on August 24, 2026, and covered various sectors such as mining, energy, and infrastructure. The bilateral trade between India and Argentina reached USD 6.5 billion in 2025, with a consistent annual growth rate of more than 17%. KABIL, an Indian company, has been actively involved in Argentina's lithium sector, with its mining activities in Catamarca progressing after completing Phase II drilling.
Both countries are also exploring emerging areas of cooperation, including aviation, space technology, telecommunications, and digital services, particularly in 5G, artificial intelligence, and digital infrastructure. The India-Mercosur Preferential Trade Agreement (PTA), which entered into effect on June 1, 2009, is set to benefit from progress on the Terms of Reference and the adoption of digital certificates of origin.
This development is expected to streamline cross-border commerce and strengthen bilateral relations between India and the Mercosur bloc, which comprises Brazil, Argentina, Uruguay, and Paraguay.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
